Atnaa Atropine And Pralidoxime Chloride Kit
Product Images NDC 11704-777

5 FDA label images from Meridian Medical Technologies, Llc · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Atnaa Atropine And Pralidoxime Chloride (NDC 11704-777). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Meridian Medical Technologies, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Atn00 0005 01

Atn00 0005 01
Chemical structure diagram showing the molecular structures of atropine and pralidoxime chloride, the active ingredients in ATNAA atropine and pralidoxime chloride Auto-Injector.*
FDA Label Image

Atn00 0005 02

Atn00 0005 02
A line graph showing plasma concentration of pralidoxime divided by dose over time in minutes. The x-axis represents time from 0 to 360 minutes, and the y-axis shows the plasma level values on a logarithmic scale ranging from 0.1 to 10. The graph depicts a declining trend in plasma concentration over the observed time period.*
FDA Label Image

Atn00 0005 03

Atn00 0005 03
A pharmacokinetic curve displaying plasma concentration of the drug over time. The graph shows a peak concentration followed by a gradual decline, with time on the x-axis and plasma concentration on the y-axis. Specific drug or study details are not visible.*
FDA Label Image

Atn00 0005 04

Atn00 0005 04
Instructional diagram for using the ATNAA atropine and pralidoxime chloride Auto-Injector kit by Meridian Medical Technologies, LLC. It shows step-by-step hand and arm illustrations demonstrating applying firm pressure, holding the device against the thigh, and activation and removal of the auto-injector for intramuscular administration.*
FDA Label Image

Atn00 0005 05

Atn00 0005 05
Label for ATNAA atropine and pralidoxime chloride Auto-Injector kit for intramuscular use. The label states the product is an antidote treatment nerve agent auto-injector intended for nerve agent poisoning. It includes instructions with three illustrations showing how to use the auto-injector, indicating a 10-second injection time. The label lists the active ingredients and strengths, storage conditions, manufacturer Meridian Medical Technologies, LLC, and NDC 11704-77701.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.